Ascent Solar Technologies Inc
Change company Symbol lookup
Select an option...
ASTI Ascent Solar Technologies Inc
HZN Horizon Global Corp
RDS.A Royal Dutch Shell PLC
GNW Genworth Financial Inc
GNMK GenMark Diagnostics Inc
GNL Global Net Lease Inc
GIGA Giga-tronics Inc
GHDX Genomic Health Inc
GGG Graco Inc
GEN Genesis Healthcare Inc
Go

Information Technology : Semiconductors & Semiconductor Equipment | Company profile

Ascent Solar Technologies, Inc. is engaged in commercializing flexible photovoltaic (PV) modules using its technology. The Company's manufacturing process deposits multiple layers of materials, including a thin film of copper-indium-gallium-diselenide (CIGS) semiconductor material, on a plastic substrate using a roll-to-roll manufacturing process and then laser patterns the layers to create interconnected PV cells or PV modules, in a process known as monolithic integration. The Company is producing consumer oriented products focusing on charging devices powered by its solar modules. It manufactures its products by affixing a thin CIGS layer to a flexible, plastic substrate using a roll-to-roll process. Its EnerPlex products are available on www.goenerplex.com and a range of third-party e-commerce sites, including www.amazon.com, www.bestbuy.com, www.walmart.com, www.newegg.com, www.frys.com, www.cabelas.com and several others.

Closing Price
$0.0038
Day's Change
-0.0004 (-9.52%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0045
Day's Low
0.0036
Volume
(Average)
Volume:
4,476,467

10-day average volume:
4,716,984
4,476,467

UPDATE: Altria to discontinue e-vape products and Verve oral nicotine and refocus on reduced-risk tobacco

2:03 pm ET December 7, 2018 (MarketWatch)
Print

Altria Group Inc. (MO) said Friday it is discontinuing its MarkTen and Green Smoke e-vape products, along with Verve oral nicotine containing products in response to regulatory restrictions that will hamper its effort to improve their financial performance. The tobacco giant said it will refocus its efforts on reduced-risk tobacco product opportunities. "We do not see a path to leadership with these particular products and believe that now is the time to refocus our resources," Chief Executive Howard Willard said in a statement. Altria is expecting to book a roughly $200 million pretax charge in the fourth quarter, most of which will be a non-cash asset impairment charge. Earlier, Altria agreed to invest $1.8 billion in Canadian weed company Cronos Corp. (CRON.T) and to be that companies exclusive partner in the cannabis sector. Shares rose 2.5% premarket, but are down 24% in 2018, while the S&P 500 has gained 0.8% and the Dow Jones Industrial Average has gained 0.9%.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

December 07, 2018 14:03 ET (19:03 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.